Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcoma.

M Glabbeke, Jaap Verweij, I Judson, OS Nielsen

Research output: Contribution to journal › Article › Academic › peer-review

390 Citations (Scopus)

Research programs

@article{fe7be2ea493049458e3b791ac29c9280,

title = "Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcoma.",

author = "M Glabbeke and Jaap Verweij and I Judson and OS Nielsen",

year = "2002",

doi = "10.1016/S0959-8049(01)00398-7",

language = "Undefined/Unknown",

volume = "38",

pages = "543--549",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcoma.

AU - Glabbeke, M

AU - Verweij, Jaap

AU - Judson, I

AU - Nielsen, OS

PY - 2002

Y1 - 2002

U2 - 10.1016/S0959-8049(01)00398-7

DO - 10.1016/S0959-8049(01)00398-7

M3 - Article

SN - 0959-8049

VL - 38

SP - 543

EP - 549

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -